Kazunari Akiyoshi

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Kyoto University, Mie University, Tokyo Medical and Dental University. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunari Akiyoshi. Retrieved from https://idiyas.com/inventor/kazunari-akiyoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 90.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 5

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 11(Granted Patents)

Location History:

Bunkyo, JP (2014)
Tokyo, JP (2015)
Bunkyo-ku, JP (2015)
Kyoto, JP (2017 - 2024)

Company Filing History:

Tokyo Medical and Dental University

patents

4. 2 out of 987

Chugai Seiyaku Kabushiki Kaisha

patents

5. 1 out of 3,208

Dai Nippon Printing Co., Ltd.

patents

6. 1 out of 1

Intellectual Property Strategy Network, Inc.

patent

7. 1 out of 1

United Immunity, Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2014-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12569562 - PRETREATMENT DRUG FOR T CELL INFUSION THERAPY FOR IMMUNE-CHECKPOINT INHIBITOR-RESISTANT TUMOR (2026-03-10),

2. 12059471 - Complex (2024-08-13),

3. 11714068 - Exosome production method (2023-08-01),

4. 11179450 - Long chain antigen containing interepitope sequence that promotes antigen presentation to T cells (2021-11-23),

5. 11083744 - Therapeutic agent associated with suppression of proliferation and metastasis of tumor, which comprises exosomes released from cytotoxic T cells and targets cancer stromal/mesenchymal cells (2021-08-10),

6. 9833407 - [object Object] (2017-12-05),

7. 9023384 - Liposome and method for injecting substance to cell using this liposome (2015-05-05),

8. 8987230 - Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same (2015-03-24),

9. 8961983 - Mucosal vaccine using cationic nanogel (2015-02-24),

10. 8759322 - Hyaluronic acid derivative and pharmaceutical composition thereof (2014-06-24),

Title: Kazunari Akiyoshi: Innovator in Biochemical Complexes

Introduction

Kazunari Akiyoshi is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of innovative techniques for forming complexes involving oligonucleotides and polysaccharides. With a total of 10 patents to his name, Akiyoshi's work has garnered attention in both academic and industrial circles.

Latest Patents

Akiyoshi's latest patents include a technique for forming CpG oligonucleotides and hydrophobized polysaccharides into complexes. This invention aims to provide a complex comprising a modified CpG oligonucleotide containing a hydrophobic group A with a sterol skeleton, and a modified polysaccharide containing a hydrophobic group B. Another notable patent is a method for preparing exosomes, which involves ultrafiltering a sample containing at least one exosome and subjecting it to anion exchange column chromatography.

Career Highlights

Throughout his career, Akiyoshi has worked with esteemed institutions such as Tokyo Medical and Dental University and Mie University. His research has focused on advancing the understanding of biochemical interactions and their applications in medicine and biotechnology.

Collaborations

Akiyoshi has collaborated with notable colleagues, including Hiroshi Shiku and Naozumi Harada. Their joint efforts have contributed to the advancement of research in their respective fields.

Conclusion

Kazunari Akiyoshi's innovative work in biochemistry has led to significant advancements in the formation of biochemical complexes. His contributions continue to influence research and development in the field.

Profile summary based on public USPTO records.